Nintedanib
Last Updated: 04/28/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 2217 publications
Salvage nintedanib plus low-dose ruxolitinib therapy for bronchiolitis obliterans syndrome refractory to calcineurin inhibitors and glucocorticoids after allogeneic transplantation.
Journal: Cell transplantation
Published: April 04, 2026
Hydrogel-Embedded Precision-Cut Lung Slices Recapitulate Fibrotic Gene Expression and Enable Therapeutic Response Evaluation.
Journal: bioRxiv : the preprint server for biology
Published: April 03, 2026
Nintedanib Eye Drops Inhibit Alkali Burn-Induced Corneal Neovascularization Via RAP1/MEK/ERK Signaling Pathway.
Journal: Investigative ophthalmology & visual science
Published: March 19, 2026
Development and Evaluation of Benzofuran Oxoacetic Acid Compounds as EPAC1 Activators.
Journal: Journal of medicinal chemistry
Published: March 14, 2026
Targeting vascular endothelial growth factor and its receptors in non-small cell lung cancer for improved treatment strategies.
Journal: Journal of receptor and signal transduction research
Published: March 12, 2026
Recent updates on engineered nanomedicines for treatment of fibrosis.
Journal: Nanomedicine (London, England)
Published: February 18, 2026
Anti-MDA5 Antibody-Positive Dermatomyositis in Emirati Patients: A Case Series Highlighting Clinical Variability.
Journal: The American journal of case reports
Published: February 17, 2026
Modeling cell-cell interactions to advance drug discovery in Idiopathic Pulmonary Fibrosis.
Journal: bioRxiv : the preprint server for biology
Published: February 12, 2026
Association of the lower-lobe volume ratio on three-dimensional computed tomography with disease progression in idiopathic pulmonary fibrosis.
Journal: Respiratory investigation
Published: January 27, 2026
Last Updated: 04/28/2026